Immuno-MALDI-TOF-MS in the Clinic

Skip to content

+1 (800) 559-9921

Shop
- Kits
  - MetaboloMetrics™ Kits
  - PeptiQuant™ Plus Kits
- Request a Quote
About Us
- Company
- Technology
Services
Bioinformatics
Products
QuaProLIMS
Workshops
News
- News
- Events
- Publications
Contact
- MRMP Europe

Immuno-MALDI-TOF-MS in the Clinic

Share:

Facebook

Twitter

Google+

Post navigation

Previous PostMeCP2-E1 isoform is a dynamically expressed, weakly DNA-bound protein with different protein and DNA interactions compared to MeCP2-E2

Next PostValidation of a proteomic biomarker panel to diagnose minor-stroke and transient ischaemic attack: phase 2 of SpecTRA, a large scale translational study

Written by Coralie Geric

What are you looking for?

Search for:

MRM Proteomics Inc. was established in 2010 as a spin-out company to commercialize the cutting-edge proteomics technologies, tools and know-how developed at the University of Victoria-Genome BC Proteomics Centre.

CONTACT

MRM Proteomics Inc.
SB-5100
141, Ave du Président-Kennedy
Montreal, QC, H2X 1Y4 Canada

Tel: +1 (800) 559-9921
Email: info@mrmproteomics.com
URL: www.mrmproteomics.com

QUICK LINKS

Company Technology Services Products News Contact

GENERAL

Terms and Conditions Shipping FAQ Privacy Policy Terms of Use Resources Calendar of Events